Combination Antifungal Therapy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.48.3.693-715.2004PMID 14982754PMCID PMC353116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review

  2005cited by this paper
• A meta-analysis of medical versus surgical therapy for Candida endocarditis.

  2005cited by this paper
• Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia

  2005cited by this paper
• Combination Therapy with Amphotericin B Lipid Complex and Caspofungin Acetate of Disseminated Zygomycosis in Diabetic Ketoacidotic Mice

  2005cited by this paper
• Emerging fungal diseases.

  2005cited by this paper
• Changing patterns and trends in systemic fungal infections.

  2005cited by this paper
• Combination Treatment of Invasive Fungal Infections

  2005cited by this paper
• Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi

  2005cited by this paper
• Berberine synergy with amphotericin B against disseminated candidiasis in mice.

  2005cited by this paper
• Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

  2005cited by this paper
• Potential for Interactions between Caspofungin and Nelfinavir or Rifampin

  2004cited by this paper
• Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B

  2004cited by this paper
• Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

  2004cited by this paper
• Combination antifungal therapy for invasive aspergillosis.

  2004cited by this paper
• In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus

  2004cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Guidelines for treatment of candidiasis.

  2004cited by this paper
• Addition of Caspofungin to Fluconazole Does Not Improve Outcome in Murine Candidiasis

  2003influential reference
• Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

  2003cited by this paper
• Synergy, antagonism, and what the chequerboard puts between them.

  2003cited by this paper
• In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.

  2003cited by this paper
• Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs.

  2003cited by this paper
• Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

  2003cited by this paper
• Efficacy of Micafungin Alone or in Combination against Systemic Murine Aspergillosis

  2003influential reference
• Simvastatin–Fluconazole Causing Rhabdomyolysis

  2003cited by this paper
• Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction

  2003cited by this paper
• Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.

  2003cited by this paper
• Scedosporium prolificans Osteomyelitis in an Immunocompetent Child Treated with Voriconazole and Caspofungin, as Well as Locally Applied Polyhexamethylene Biguanide

  2003cited by this paper
• Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery

  2003cited by this paper
• A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

  2003cited by this paper
• Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine

  2003cited by this paper
• A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.

  2003cited by this paper
• In Vitro Synergy of Caspofungin and Itraconazole against Aspergillus spp.: MIC versus Minimal Effective Concentration End Points

  2003cited by this paper
• Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei

  2003cited by this paper
• Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.

  2003cited by this paper
• Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods.

  2002influential reference
• In Vitro Activities of Terbinafine in Combination with Fluconazole, Itraconazole, Voriconazole, and Posaconazole against Clinical Isolates of Candida glabrata with Decreased Susceptibility to Azoles

  2002cited by this paper
• Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis

  2002cited by this paper
• In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents

  2002cited by this paper
• Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.

  2002cited by this paper
• Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

  2002cited by this paper
• Experimental application of the median-effect principle for in vitro quantification of the combined inhibitory activities of clavulanic acid and imipenem against IRT-4 beta-lactamase.

  2002cited by this paper
• Combination therapy with caspofungin and amphotericin B lipid complex.

  2002cited by this paper
• Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.

  2002cited by this paper
• Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

  2002cited by this paper
• In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp

  2002cited by this paper
• Comparison of Fractional Inhibitory Concentration Index with Response Surface Modeling for Characterization of In Vitro Interaction of Antifungals against Itraconazole-Susceptible and -Resistant Aspergillus fumigatus Isolates

  2002cited by this paper
• In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

  2002influential reference
• Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.

  2002influential reference
• Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

  2002cited by this paper
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  2002cited by this paper
• Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.

  2002cited by this paper
• Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

  2002cited by this paper
• Decision to delivery for assisted vaginal vertex delivery.

  2001cited by this paper
• Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.

  2001cited by this paper
• Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.

  2001cited by this paper
• Nucleic Acid Sequence-Based Amplification ofAspergillus RNA in Blood Samples

  2001cited by this paper
• The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy.

  2001cited by this paper
• Antifungal prophylaxis in hematopoietic stem cell transplant recipients

  2001cited by this paper
• Aspergillus fumigatus Cranial Infection After Accidental Traumatism

  2001cited by this paper
• Successful treatment of cryptococcal osteomyelitis and paraspinous abscess with fluconazole and flucytosine.

  2001cited by this paper
• Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy

  2001cited by this paper
• Utility of 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenyl-Amino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) and Minimum Effective Concentration Assays in the Determination of Antifungal Susceptibility of Aspergillus fumigatus to the Lipopeptide Class of Compounds

  2001cited by this paper
• Evaluation of Polyene-Azole Antagonism in Liquid Cultures of Candida albicans Using an Automated Turbidometric Method

  2001cited by this paper
• The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients

  2001cited by this paper
• Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.

  2001cited by this paper
• Candida glabrata infection after total hip arthroplasty.

  2001cited by this paper
• Impact of the Order of Initiation of Fluconazole and Amphotericin B in Sequential or Combination Therapy on Killing of Candida albicans In Vitro and in a Rabbit Model of Endocarditis and Pyelonephritis

  2001cited by this paper
• Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.

  2001cited by this paper
• Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.

  2001cited by this paper
• Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

  2001cited by this paper
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates

  2001cited by this paper
• Interactions of Posaconazole and Flucytosine against Cryptococcus neoformans

  2001cited by this paper
• Rationale for Combination Antifungal Therapy

  2001cited by this paper
• Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA).

  2001cited by this paper
• The use of itraconazole as prophylaxis against invasive fungal infection in blood and marrow transplant recipients

  2000cited by this paper
• Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species.

  2000cited by this paper
• In-Vitro Synergistic Effect of Fluconazole with Nonsteroidal Anti-Inflammatory Agents Against Candida albicans Strains

  2000cited by this paper
• Rational approach to the clinical protocol design for drug combinations: a review.

  2000cited by this paper
• Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans

  2000cited by this paper
• Synergistic Antifungal Activities of Bafilomycin A1, Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against Cryptococcus neoformans

  2000cited by this paper
• Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.

  2000cited by this paper
• Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B

  2000cited by this paper
• Itraconazole-Amphotericin B Antagonism inAspergillus fumigatus: an E-Test-Based Strategy

  2000cited by this paper
• Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

  2000cited by this paper
• Practice Guidelines for Diseases Caused by Aspergillus

  2000cited by this paper
• Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

  2000influential reference
• Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.

  2000cited by this paper
• Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction

  2000cited by this paper
• SUCCESSFUL TREATMENT OF ASPERGILLUS BRAIN ABSCESS IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  2000cited by this paper
• Antifungal Pharmacodynamics: Review of the Literature and Clinical Applications

  2000cited by this paper
• Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

  2000cited by this paper
• Quantification of Fungal DNA by Using Fluorescence Resonance Energy Transfer and the Light Cycler System

  2000cited by this paper
• Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

  2000cited by this paper
• Identification of rare Candida species and other yeasts by polymerase chain reaction and slot blot hybridization.

  2000cited by this paper
• Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans

  2000cited by this paper
• The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans.

  2000cited by this paper
• Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

  2000cited by this paper
• Combination Antifungal Therapy in Treatment of Murine Pulmonary Mucormycosis: Roles of Quinolones and Azoles

  2000cited by this paper
• Prophylaxis and treatment of fungal infections associated with haematological malignancies.

  2000cited by this paper

• Anti-psychotic drugs act synergistically in combination with antifungal drugs to inhibit drug-resistant Cryptococcus and Candida species

  2026cites this paper
• Successful combination therapy with voriconazole and micafungin for voriconazole-resistant Scedosporium dehoogii pulmonary infection: A case report with in vitro analysis.

  2025cites this paper
• Fluconazole, thymol, and geraniol association in beta-cyclodextrin inclusion complexes: spectroscopic and thermal studies

  2025cites this paper
• 8-Hydroxyquinoline derivative as a promising antifungal agent to combat ocular fungal infections.

  2025cites this paper
• Non-antifungal medications administered during fungal infections drive drug tolerance and resistance in Candida albicans

  2025influential citation
• Combined Effect of Honey from Central West Brazil on Bacterial Membrane Permeability

  2025cites this paper
• In vitro study of essential oils encapsulated in chitosan microparticles against Histoplasma capsulatum and their pathogenicity in Caenorhabditis elegans

  2025cites this paper
• Evaluating the combined impact of amphotericin B and posaconazole on the germination of a rare Rhizopus homothallicus isolate responsible for COVID-19 associated mucormycosis.

  2025cites this paper
• In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis

  2025influential citation
• Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles’ antifungal activities

  2025cites this paper
• In vitro evaluation of olorofim and antifungal combinations against Aspergillus and Candida species

  2025influential citation
• Drug Interactions of Antifungal Agents: Clinical Relevance and Implications

  2025cites this paper
• In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis

  2025influential citation
• Molecular landscape of the fungal plasma membrane and implications for antifungal action

  2025influential citation
• Unravelling azole resistance in fungal pathogens: molecular mechanisms, diagnostic challenges, and therapeutic strategies

  2025cites this paper
• Anticandidal and Antibiofilm Activity of the Essential Oils from the Leaves of Citrus limon and Citrus sinensis

  2025cites this paper
• Investigation of the antifungal activity of panobinostat, tamoxifen, and miltefosine alone and in combination with some conventional antifungal drugs against fluconazole-resistant Candida species

  2025cites this paper
• Structure-guided identification and characterization of potent inhibitors targeting PhoP and MtrA to combat mycobacteria

  2024cites this paper
• Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species

  2024influential citation
• Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) Trial

  2024influential citation
• Chemical composition, antifungal activity and toxicological evaluation of Lippia sidoides Cham

  2024cites this paper
• DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases

  2024cites this paper
• Two promising Bacillus-derived antifungal lipopeptide leads AF4 and AF5 and their combined effect with fluconazole on the in vitro Candida glabrata biofilms

  2024influential citation
• Synergistic Antifungal Effect and In Vivo Toxicity of a Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels

  2024cites this paper
• Mechanistic Insights into Cellular and Molecular Targets of Zinc Oxide Quantum Dots (ZnO QDs) in Fungal Pathogen, Candida albicans: One Drug Multi-Targeted Therapeutic Approach.

  2024cites this paper
• Antifungal activity of azoles, allylamines, and 8-hidroxiquinolines, alone and in combination, against Malassezia pachydermatis in vitro and in vivo.

  2024cites this paper
• Halofantrine Hydrochloride Acts as an Antioxidant Ability Inhibitor That Enhances Oxidative Stress Damage to Candida albicans

  2024influential citation
• Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris

  2024cites this paper
• In vitro determination of the combination of ciclopirox and terbinafine in the treatment of dermatophytosis.

  2024cites this paper
• Four-Arm δ-Ornithine-Based Polypeptoids Resensitize Voriconazole against Azole-Resistant C. albicans.

  2024cites this paper
• Enhanced photodynamic effect of a natural anthraquinone on Candida tropicalis biofilms using a stepwise irradiation strategy.

  2024cites this paper
• Investigating role of positively selected genes and mutation sites of ERG11 in drug resistance of Candida albicans

  2024cites this paper
• Eutectic binary phase diagram and kinetically stable homogeneous co-amorphous mixtures of two imidazole drugs

  2024cites this paper
• Pythium insidiosum: In vitro oomicidal evaluation of telithromycin and interactions with azithromycin and amorolfine hydrochloride.

  2024cites this paper
• Etiopathology, Epidemiology, Diagnosis, and Treatment of Fungal Keratitis.

  2024cites this paper
• Green Synthesis of Cocos nucifera-Based Nanomaterials and Mechanistic Basis of Their Antimicrobial Action

  2024cites this paper
• In Vitro–In Vivo Correlation of Posaconazole–Amphotericin B Combination against Candida albicans: In Vitro Interacting Concentrations Are Associated with In Vivo Free Drug Levels

  2023cites this paper
• New Oxadiazole/Triazole Derivatives with Antimicrobial and Antioxidant Properties

  2023cites this paper
• The Chemical Profile, and Antidermatophytic, Anti-Inflammatory, Antioxidant and Antitumor Activities of Withania chevalieri A.E. Gonç. Ethanolic Extract

  2023influential citation
• Understanding Fluconazole Tolerance in Candida albicans: Implications for Effective Treatment of Candidiasis and Combating Invasive Fungal Infections.

  2023cites this paper
• Antifungal Activity of Chitosan against Histoplasma capsulatum in Planktonic and Biofilm Forms: A Therapeutic Strategy in the Future?

  2023cites this paper
• An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis and cruris

  2023cites this paper
• Antifungal activity of selective serotonin reuptake inhibitors against Cryptococcus spp. and their possible mechanism of action.

  2023cites this paper
• Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources

  2023cites this paper
• In vitro evaluation of the efficacy of 8-hydroxyquinoline derivatives for the control of Phaeomoniella chlamydospora, the causative agent of Petri disease in grapevines.

  2023cites this paper
• New antifungal strategies: drug combination and co-delivery.

  2023cites this paper
• Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs

  2023cites this paper
• Molecular complexes of drug combinations: a review of cocrystals, salts, coamorphous systems and amorphous solid dispersions.

  2023cites this paper
• Synergistic Growth Inhibition of Herbal Plant Extract Combinations against Candida albicans

  2023cites this paper
• Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris

  2023cites this paper
• The first evidence of antibiofilm action of Proteus mirabilis with tetra-cationic porphyrins containing cisplatin by antimicrobial photodynamic therapy.

  2022cites this paper
• Evaluation of the efficacy of heat shock protein inhibitors and antifungal drug combinations against Candida spp.

  2022cites this paper
• Antifungal Combination Eye Drops for Fungal Keratitis Treatment

  2022cites this paper
• Development and validation of a sensitive LC-MS/MS method for determination of intracellular concentration of fluconazole in Candida albicans

  2022cites this paper
• Development of Antimicrobial Peptide-Antibiotic Conjugates to Improve the Outer Membrane Permeability of Antibiotics Against Gram-Negative Bacteria.

  2022cites this paper
• In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates

  2022cites this paper
• Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis

  2022cites this paper
• Therapeutic potential of Calotropis gigantea extract against invasive pulmonary aspergillosis: In vitro and in vivo study

  2022cites this paper
• Potential risks of treating bacterial infections with a combination of β-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates

  2022cites this paper
• Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

  2022cites this paper
• In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species

  2022cites this paper
• Association of the essential oil of Cymbopogon citratus (DC) Stapf with nystatin against oral cavity yeasts.

  2022cites this paper
• Hydroalcoholic Leaf Extract of Punica granatum, alone and in Combination with Calcium Hydroxide, Is Effective against Mono- and Polymicrobial Biofilms of Enterococcus faecalis and Candida albicans

  2022cites this paper
• Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs

  2022cites this paper
• In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections

  2022cites this paper
• In vitro activity of immunosuppressive agents against Cryptococcus neoformans.

  2022cites this paper
• Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against Candida glabrata

  2022cites this paper
• Phytochemical profiling of Piper crocatum and its antifungal mechanism action as Lanosterol 14 alpha demethylase CYP51 inhibitor: a review

  2022cites this paper
• Discovery and Characterization of a Rapidly Fungicidal and Minimally Toxic Peptoid against Cryptococcus neoformans.

  2021cites this paper
• Deciphering the Mechanism of Action of Armeniaspirol: A Polyketide Gram-Positive Antibiotic

  2021cites this paper
• Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study

  2021cites this paper
• Anti-Candida activity of Tripodanthus acutifolius (Loranthaceae), mechanism of action and toxicity parameters

  2021cites this paper
• 8-hydroxyquinoline-5-(N-4-chlorophenyl) sulfonamide and fluconazole combination as a preventive strategy for Candida biofilm in haemodialysis devices.

  2021cites this paper
• Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of Scedosporium and Fusarium spp.

  2021cites this paper
• Rondonin: antimicrobial properties and mechanism of action

  2021cites this paper
• Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage

  2021cites this paper
• Synergistic Activity of New Diclofenac and Essential Oils Combinations against Different Candida spp.

  2021cites this paper
• Post-transcriptional and translational control of the morphology and virulence in human fungal pathogens.

  2021cites this paper
• In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible Candida glabrata

  2021cites this paper
• Limonene-carvacrol: A combination of monoterpenes with enhanced antileishmanial activity.

  2021cites this paper
• Diabetic Foot Ulcer: An Update

  2021cites this paper
• Fingolimod Potentiates the Antifungal Activity of Amphotericin B

  2021cites this paper
• Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

  2021cites this paper
• Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation

  2021cites this paper
• Antifungal and antioxidant effect of the lachnophyllum ester, isolated from the essential oil of Baccharis trinervis (Lam.) Pers., against dermatophytes fungi

  2021cites this paper
• Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story

  2021influential citation
• The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na+/H+ Exchangers

  2021cites this paper
• Antibacterial, Antibiofilm, and Synergistic Effects of Eremanthus crotonoides Against Multidrug-Resistant Staphylococcus Strains

  2021cites this paper
• Combination therapy: Current status and future perspectives

  2020cites this paper
• Intravenous therapy for chronic pulmonary aspergillosis: A systematic review and meta‐analysis

  2020cites this paper
• In vitro antidermatophytic synergism of double and triple combination of clioquinol with ciclopirox and terbinafine

  2020cites this paper
• Antifungal and Antioxidant Activities of Vernonia Chalybaea Mart. ex DC. Essential Oil and their Major Constituent β-caryophyllene

  2020influential citation
• Antimicrobial activity of geraniol: an integrative review

  2020cites this paper
• Combination therapy against human infections caused by Candida species

  2020cites this paper
• In vitro anti-Pythium insidiosum activity of amorolfine hydrochloride and azithromycin, alone and in combination.

  2020cites this paper
• Cytotoxic and Antifungal Activity of Chalcones Synthesized from Natural Acetophenone Isolated from Croton anisodontus

  2020cites this paper
• Evaluation of synergistic action between nimesulide and the antifungals ketoconazole and nystatin on clinical cervical-vaginal isolates of Candida spp.

  2020cites this paper
• Optimum Inhibition of Amphotericin-B-Resistant Candida albicans Strain in Single- and Mixed-Species Biofilms by Candida and Non-Candida Terpenoids

  2020influential citation
• Combination Therapy for Invasive Fungal Infections

  2020cites this paper
• The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms

  2020cites this paper